Skip to main content
logo
Seaport Therapeutics, Inc. (SPTX)
NASDAQ: SPTX · Real-Time Price · USD
22.39
+1.27 (6.01%)
Sep 22, 2026, 4:00 PM EDT - Market closed

Seaport Therapeutics Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024
Period Ending
Jun '26 Dec '25 Dec '24
Net Income
-134.69-74.88-46.88
Depreciation & Amortization
1.441.410.21
Loss (Gain) From Sale of Assets
0.010.01-
Loss (Gain) From Sale of Investments
-1.99-3.43-
Stock-Based Compensation
42.946.8814.52
Change in Accounts Payable
3.57-2.731.72
Change in Other Net Operating Assets
-0.01-5.20.79
Operating Cash Flow
-88.73-77.94-29.63
Operating Cash Flow Growth
---

Investing Activities

Fiscal Year
TTMFY 2025FY 2024
Period Ending
Jun '26 Dec '25 Dec '24
Capital Expenditures
-0.03-0.36-0.11
Investment in Securities
-132.87-183.89-
Investing Cash Flow
-132.9-184.25-0.11

Financing Activities

Fiscal Year
TTMFY 2025FY 2024
Period Ending
Jun '26 Dec '25 Dec '24
Issuance of Common Stock
240.150-
Other Financing Activities
-0.87-0.8713.2
Financing Cash Flow
239.27-0.87339.3

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024
Period Ending
Jun '26 Dec '25 Dec '24
Foreign Exchange Rate Adjustments
00-
Net Cash Flow
17.65-263.06309.55

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024
Period Ending
Jun '26 Dec '25 Dec '24
Free Cash Flow
-88.76-78.3-29.74
Free Cash Flow Growth
---
Free Cash Flow Per Share
-5.60-10.50-10.04
Levered Free Cash Flow
--50.78-
Unlevered Free Cash Flow
--50.78-

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024
Period Ending
Jun '26 Dec '25 Dec '24
Cash Income Tax Paid
0.260.26-
Change in Working Capital
3.56-7.932.51
SEC Filings: 10-K · 10-Q